GlassScriptPhysician profile
Hassan Alkhatib
NPI 1952630105
$2,235.31
in general payments reported to CMS, 2019-2025
22 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.11 · 2020: $104 · 2021: $224 · 2022: $182 · 2023: $637 · 2024: $591 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.50 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $489.89 | 2021-2025 | Vraylar, Ubrelvy, Botox |
| Novo Nordisk INC | $385.11 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $300.84 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $152.34 | 2023-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $151.29 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.08 | 2019-2023 | Jardiance |
| Daiichi Sankyo INC. | $133.33 | 2021-2025 | Injectafer |
| Corium, LLC | $77.33 | 2022-2023 | Azstarys |
| G1 Therapeutics, INC. | $62.99 | 2022 | |
| Medicomp INC | $56.81 | 2023 | Telepatch Cardiac Monitor |
| Biotronik Nro, INC. | $33.03 | 2025 | Prospera |
| Nevro Corp. | $32.28 | 2024 | Senza |
| Organogenesis INC. | $29.85 | 2025 | Puraply Wound Matrix |
| Ferring Pharmaceuticals INC. | $28.90 | 2022-2023 | Rebyota |
| Insulet Corporation | $24.06 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.03 | 2024 | Intellis Adaptivestim |
| Exact Sciences Corporation | $22.03 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $21.30 | 2023 | |
| Bardy Diagnostics, INC. | $20.00 | 2021 | |
| Dexcom, INC. | $18.12 | 2023 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $14.54 | 2021 | |
| Abbott Laboratories | $13.16 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Alkhatib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.